MaxCyte, Inc.
A cell-engineering platform using non-viral technology to advance cell-based therapies.
Overview
Corporate Details
- ISIN(s):
- US57777K1060 (+2 more)
- LEI:
- 54930053YHXULRFCU991
- Country:
- United States of America
- Address:
- 9713 Key West Avenue, 20850 Rockville
- Website:
- https://www.maxcyte.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
MaxCyte, Inc. is a commercial-stage cell-engineering company providing platform technologies to advance the discovery, development, and commercialization of cell-based therapies. The company's core offering is the ExPERT™ platform, which utilizes its proprietary, non-viral Flow Electroporation® technology for efficient and scalable transfection of complex cells. Its technology supports applications in cell therapy, gene editing, antibody and protein production, and vaccine development. MaxCyte also offers SeQure™ gene editing risk assessment services to ensure therapeutic safety and precision. The company operates on a partnership-driven licensing model, supporting partners from initial research through to clinical and commercial stages, helping to accelerate development and mitigate risk.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-26 11:14 |
Director's Dealing
Correction: Vesting of RSUs and PDMR Dealing
|
English | 57.0 KB | ||
| 2025-03-26 08:00 |
Director's Dealing
Vesting of RSUs and PDMR Dealing
|
English | 55.7 KB | ||
| 2025-03-25 11:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 88.0 KB | ||
| 2025-03-25 11:28 |
Major Shareholding Notification
Holding(s) in Company
|
English | 87.7 KB | ||
| 2025-03-25 11:26 |
Major Shareholding Notification
Holding(s) in Company
|
English | 87.8 KB | ||
| 2025-03-25 11:22 |
Major Shareholding Notification
Holding(s) in Company
|
English | 87.8 KB |
Automate Your Workflow. Get a real-time feed of all MaxCyte, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for MaxCyte, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Spermosens_AB_publ-logo.jpg){kind=logo}
